- Report
- January 2024
- 120 Pages
Global
From €6941EUR$7,950USD£6,010GBP
- Drug Pipelines
- January 2024
- 136 Pages
Global
From €6548EUR$7,500USD£5,669GBP
- Report
- January 2024
- 145 Pages
Global
From €6941EUR$7,950USD£6,010GBP
- Report
- January 2024
- 158 Pages
Global
From €6548EUR$7,500USD£5,669GBP
- Report
- January 2024
- 160 Pages
Global
From €6548EUR$7,500USD£5,669GBP
- Report
- January 2024
- 267 Pages
Japan
From €3274EUR$3,750USD£2,835GBP
- Report
- January 2024
- 106 Pages
Global
From €3449EUR$3,950USD£2,986GBP
- Report
- January 2024
- 216 Pages
United States
From €3274EUR$3,750USD£2,835GBP
- Report
- January 2024
- 129 Pages
United States
From €3274EUR$3,750USD£2,835GBP
- Report
- January 2024
- 395 Pages
Global
From €6548EUR$7,500USD£5,669GBP
- Report
- January 2024
- 132 Pages
Global
From €6941EUR$7,950USD£6,010GBP
- Report
- January 2024
- 160 Pages
Global
From €6548EUR$7,500USD£5,669GBP
- Report
- January 2024
- 161 Pages
Global
From €6548EUR$7,500USD£5,669GBP
- Report
- January 2024
- 189 Pages
Global
From €6548EUR$7,500USD£5,669GBP
- Report
- January 2024
- 133 Pages
Global
From €6941EUR$7,950USD£6,010GBP
- Report
- January 2024
- 289 Pages
Global
From €6548EUR$7,500USD£5,669GBP
- Report
- January 2024
- 84 Pages
Global
From €3449EUR$3,950USD£2,986GBP
- Report
- January 2024
- 120 Pages
Global
From €6941EUR$7,950USD£6,010GBP
- Report
- January 2024
- 143 Pages
Global
From €6941EUR$7,950USD£6,010GBP
- Report
- January 2024
- 80 Pages
Global
From €3449EUR$3,950USD£2,986GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more